OIA
INZY

OneDigital Investment Advisors’s Inozyme Pharma INZY Stock Holding History

OneDigital Investment Advisors’s Portfolio INZY Stock Details INZY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-81,000
Closed -$73.7K – 1485
2025
Q1 		$73.7K Buy
81,000
+30,000
+59% +$41.6K ﹤0.01% 1368
2024
Q4 		$141K Buy
51,000
+31,000
+155% +$118K ﹤0.01% 1352
2024
Q3 		$105K Buy
20,000
+6,800
+52% +$35.3K ﹤0.01% 1400
2024
Q2 		$58.9K Sell
13,200
-450
-3% -$2.18K ﹤0.01% 1338
2024
Q1 		$105K Buy
+13,650
New +$74.9K ﹤0.01% 1055

Other funds holding INZY

BCM
Beryl Capital Management Redondo Beach, California $110M AUM 317.92% 1-Year Est. Return
PBPIA
Pivotal bioVenture Partners Investment Advisor San Francisco, California $280M AUM 181.4% 1-Year Est. Return
GCL
Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
OBAM
ODDO BHF Asset Management Paris, France $2.54B AUM 41.83% 1-Year Est. Return
TC
Trium Capital London, United Kingdom $163M AUM 45.8% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.6B AUM 93.19% 1-Year Est. Return

OneDigital Investment Advisors's INZY Position: Q2 2025 in Review

OneDigital Investment Advisors sold out of Inozyme Pharma (INZY) in Q2 2025, closing a stake of 81,000 shares — an estimated $73.7K sold.

OneDigital Investment Advisors first reported a position in INZY in Q1 2024 and held it in 5 quarters. The position peaked at $141K in Q4 2024. 86 funds tracked by Wall St. Rank hold INZY as of Q2 2025.

  • OneDigital Investment Advisors reported no remaining Inozyme Pharma position as of Q2 2025 after selling out during the quarter.
  • OneDigital Investment Advisors sold 81,000 Inozyme Pharma shares in Q2 2025, an estimated $73.7K.
  • OneDigital Investment Advisors first reported a position in Inozyme Pharma in Q1 2024 and held it in 5 quarters.
  • OneDigital Investment Advisors's Inozyme Pharma position peaked at $141K in Q4 2024.
  • 86 funds tracked by Wall St. Rank held Inozyme Pharma as of Q2 2025.

Based on OneDigital Investment Advisors's 13F filing for Q2 2025, filed 7 Aug 2025.